Illumeo System vs ContaCT
AI Verdict
Choose Illumeo System if…
Choose Illumeo System if your institution's primary goal is to enhance the radiologist's diagnostic capabilities and efficiency directly within the imaging workflow. This platform is ideal for reducing variability in image interpretation and generating comprehensive, dynamic reports through adaptive intelligence and advanced data analytics.
View Illumeo System →Choose ContaCT if…
Choose ContaCT if your institution prioritizes rapid, AI-powered disease detection and streamlined care coordination for time-sensitive conditions like stroke, pulmonary embolism, or cerebral aneurysm. This platform excels at accelerating patient treatment through real-time alerts, mobile image viewing, and secure communication among specialists across the care continuum.
View ContaCT →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Illumeo System | ContaCT |
|---|---|---|
| Pricing | Not publicly available | Subscription-based |
| Deployment | Integrates with existing healthcare IT systems (e.g., Philips IntelliSpace PACS, EMR/RIS); Enterprise viewer is HTML5-based and zero-footprint. | Cloud-based, integrates with existing hospital IT infrastructure (PACS, EHR). |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ContaCTTool B offers a strong mobile application for specialists, enabling real-time image viewing and secure communication, which is crucial for rapid decision-making in acute care. While Tool A's HTML5 zero-footprint viewer is convenient, Tool B's mobile-first approach for specialists provides a more immediate and actionable user experience for its target workflows.
Clinical Value
ContaCTTool B explicitly focuses on AI-powered disease detection for multiple critical, time-sensitive conditions like stroke (LVO, ICH) and pulmonary embolism, with real-time alerts and guideline-based recommendations. Its multiple FDA clearances and deployment in over 1,700 hospitals globally demonstrate a proven impact on accelerating treatment and improving patient outcomes. Tool A, while enhancing radiology workflow, does not detail the same direct, measurable impact on acute disease intervention.
Pricing & Value
ContaCTTool B, while not fully transparent, at least specifies a 'subscription-based' model and indicates that pricing varies based on factors like organization size and features, often tiered for different types of stroke centers. Tool A provides no public pricing information whatsoever, making it harder for potential buyers to gauge initial costs or value propositions.
Enterprise Readiness
ContaCTTool B demonstrates strong enterprise readiness through its cloud-based deployment and integration with existing hospital IT infrastructure (PACS, EHR), coupled with its widespread adoption in over 1,700 hospitals globally. This extensive real-world deployment provides concrete evidence of its scalability and ability to operate effectively within diverse healthcare environments. Tool A, while from Philips and integrating with IT systems, does not provide comparable metrics of global adoption.
Innovation
ContaCTTool B is described as a 'pioneering AI-powered care coordination platform' that combines multi-disease detection, real-time alerts, mobile communication, and automated chart summarization to optimize the entire patient pathway for time-sensitive conditions. This comprehensive approach to streamlining care delivery represents a broader and more impactful innovation. Tool A's innovation is more focused on augmenting the radiology interpretation and reporting process.
Support & Docs
TieThe provided structured facts and general web searches do not offer sufficient specific information to differentiate between the two tools regarding their support and documentation offerings. Neither tool's documentation or support structure is detailed enough to declare a winner in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Illumeo System | ContaCT |
|---|---|---|
| Product Name | Illumeo System | ContaCT |
| Company | Philips Medical Systems Technologies | Viz.AI |
| Tagline | Adaptive Intelligence Technology for Radiology | The leading AI care coordination platform for disease detection and workflow optimization. |
| Description | Philips Illumeo is an imaging and informatics platform with adaptive intelligence (AI) that augments clinicians' skills and redefines how they interact with images, enhancing their expertise and efficiency, and supporting variability reduction throughout the institution. | Viz.ai is a pioneering AI-powered care coordination platform that accelerates disease detection and streamlines clinical workflows. With multiple FDA clearances, including the initial Viz.AI Contact application for stroke, it helps ensure patients receive timely treatment across over 1,700 hospitals globally. |
| Primary Categories | Radiology & Imaging AI | Neurology AI, Radiology & Imaging AI |
| Key Features | Adaptive Intelligence, Contextual Awareness, Advanced Data Analytics, Integration with PACS/EMR/RIS, Patient Briefing Feature, Anatomy-Aware Capabilities, Intelligent Clinical Semantic Labeling Engine, Dynamic Report Generation (including 3D images) | AI-powered disease detection (LVO, ICH, HCM, PE, Aneurysm), Real-time AI-powered alerts and notifications, Mobile application for specialists to view images and communicate, Secure, HIPAA-compliant group communication messaging, Integration with PACS and EHR systems, High-fidelity 3D web and mobile image viewer, Automated chart summarization, Guideline-based recommendations |
Videos
Demos, reviews, and walkthroughs featuring Illumeo System and ContaCT.